Kintor Pharmaceutical Limited

KNTPF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$155-$1,069-$1-$1
Dep. & Amort.$18$19$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.-$9$0$0$0
Change in WC-$51-$96-$198-$285
Other Non-Cash-$1$759$198$284
Operating Cash Flow-$199-$388-$1-$1
Investing Activities
PP&E Inv.-$2-$0-$0-$0
Net Acquisitions$0$0-$19-$196
Inv. Purchases-$0-$137-$221-$515
Inv. Sales/Matur.$10$136$337$711
Other Inv. Act.$12$4-$98$0
Investing Cash Flow$20$3$0$0
Financing Activities
Debt Repay.-$115-$29$122-$64
Stock Issued$0$1$699$952
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$5-$5-$820-$888
Financing Cash Flow-$120-$33$1$1
Forex Effect$2-$3$0-$0
Net Chg. in Cash-$297-$420-$0-$0
Supplemental Information
Beg. Cash$444$864$1$1
End Cash$147$444$1$1
Free Cash Flow-$201-$390-$1-$1